These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 23748811)
1. Sorafenib acts synergistically in combination with radiotherapy without causing intestinal damage in colorectal cancer. Jeong YK; Kim MS; Lee JY; Kim EH; Kim W; Ha H; Jeong JH Tumori; 2013; 99(2):176-82. PubMed ID: 23748811 [TBL] [Abstract][Full Text] [Related]
2. The mechanisms responsible for the radiosensitizing effects of sorafenib on colon cancer cells. Kim EH; Kim MS; Jung WG Oncol Rep; 2014 Dec; 32(6):2421-8. PubMed ID: 25242034 [TBL] [Abstract][Full Text] [Related]
3. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner. Li Q; Hu Y; Xi M; He L; Zhao L; Liu M BMC Cancer; 2012 Oct; 12():485. PubMed ID: 23088517 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells. Kim EH; Lee H; Jeong YK; Jung WG Oncol Rep; 2016 Aug; 36(2):763-70. PubMed ID: 27373272 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer. Kim YB; Jeung HC; Jeong I; Lee K; Rha SY; Chung HC; Kim GE J Radiat Res; 2013 Jan; 54(1):52-60. PubMed ID: 22923745 [TBL] [Abstract][Full Text] [Related]
6. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells. Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558 [TBL] [Abstract][Full Text] [Related]
7. Sorafenib and radiation: a promising combination in colorectal cancer. Suen AW; Galoforo S; Marples B; McGonagle M; Downing L; Martinez AA; Robertson JM; Wilson GD Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):213-20. PubMed ID: 20708486 [TBL] [Abstract][Full Text] [Related]
8. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis. Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo. Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104 [TBL] [Abstract][Full Text] [Related]
10. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3. Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751 [TBL] [Abstract][Full Text] [Related]
11. Combination effect of cetuximab with radiation in colorectal cancer cells. Shin HK; Kim MS; Lee JK; Lee SS; Ji YH; Kim JI; Jeong JH Tumori; 2010; 96(5):713-20. PubMed ID: 21302618 [TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway. Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo. Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289 [TBL] [Abstract][Full Text] [Related]
14. Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft--no benefit of combination therapy. Wehler TC; Hamdi S; Maderer A; Graf C; Gockel I; Schmidtmann I; Hainz M; Berger MR; Theobald M; Galle PR; Moehler M; Schimanski CC Int J Colorectal Dis; 2013 Mar; 28(3):385-98. PubMed ID: 22983756 [TBL] [Abstract][Full Text] [Related]
15. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL. Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258 [TBL] [Abstract][Full Text] [Related]
16. Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins. Jeong YK; Kim MS; Lee JY; Kim EH; Ha H PLoS One; 2015; 10(11):e0143596. PubMed ID: 26599019 [TBL] [Abstract][Full Text] [Related]
17. The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer. He S; Smith DL; Sequeira M; Sang J; Bates RC; Proia DA Invest New Drugs; 2014 Aug; 32(4):577-86. PubMed ID: 24682747 [TBL] [Abstract][Full Text] [Related]
18. Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells. Kim JG; Bae JH; Kim JA; Heo K; Yang K; Yi JM PLoS One; 2014; 9(8):e105405. PubMed ID: 25136811 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells. Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909 [TBL] [Abstract][Full Text] [Related]
20. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells. Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]